Herantis Pharma Oyj (HRTIS.HE)

EUR 1.66

(0.91%)

Annual Income Statements

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue - - - 927.7 Thousand - 1.2 Million
Gross Profit - - - -927.7 Thousand -1.04 Million -1.2 Million
Operating Expenses -154.36 Thousand 7.99 Million 9.04 Million 8.07 Million 7.15 Million 3.66 Million
Selling, General and Administrative Expenses 1735.16 2.64 Million 2.84 Million 2.83 Million 2.33 Million 1.24 Million
Research and Development Expenses 2.7 Million 5 Million 6.2 Million 5.32 Million 4.92 Million 2.1 Million
Other Expenses -2.85 Million - 1.29 Million 709.08 Thousand 824.29 Thousand 230.1 Thousand
Cost and Expenses -154.36 Thousand 7.99 Million 12.46 Million 8.07 Million 7.15 Million 4.87 Million
Operating Income 154.36 Thousand -7.99 Million -9.04 Million -8.07 Million -7.15 Million -4.87 Million
Interest Expense 551.59 Thousand 1.33 Million 63.02 Thousand 1.08 Million 868.79 Thousand 60.63 Thousand
Income Tax Expense -1.00 - - - - -1.63
Earnings before Tax 279.83 Thousand -9.32 Million -12.76 Million -9.15 Million -8 Million -4.17 Million
Net Income 279.84 Thousand -9.32 Million -23.57 Million -9.15 Million -8 Million -4.17 Million
Earnings Per Share Basic 0.02 -0.64 -2.20 -1.18 -1.30 -0.85
Earnings Per Share Diluted 0.02 -0.64 -2.20 -1.18 -1.30 -0.85
Weighted Average Shares Outstanding 17.19 Million 14.65 Million 10.2 Million 7.77 Million 6.14 Million 4.91 Million
Weighted Average Shares Outstanding (Diluted) 17.19 Million 14.65 Million 10.2 Million 7.77 Million 6.14 Million 4.91 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA 831.43 Thousand 7.97 Million 6.92 Million -7.14 Million -6.08 Million -2.91 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts